This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1980;72(1):27-33.

doi: 10.1007/BF00433804.

Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain

N A Garrick, D L Murphy

PMID: 6781004
DOI: 10.1007/BF00433804

Comparative Study

Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain

N A Garrick et al. Psychopharmacology (Berl). 1980.

. 1980;72(1):27-33.

doi: 10.1007/BF00433804.

Authors

N A Garrick, D L Murphy

PMID: 6781004
DOI: 10.1007/BF00433804

No abstract available

PubMed Disclaimer

Similar articles

The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions.
O'Carroll AM, Fowler CJ, Phillips JP, Tobbia I, Tipton KF. O'Carroll AM, et al. Naunyn Schmiedebergs Arch Pharmacol. 1983 Apr;322(3):198-202. doi: 10.1007/BF00500765. Naunyn Schmiedebergs Arch Pharmacol. 1983. PMID: 6408492
Distribution and inhibition characteristics of human brain monoamine oxidase.
Owen F, Cross AJ, Lofthouse R, Glover V. Owen F, et al. Biochem Pharmacol. 1979 Apr 1;28(7):1077-80. doi: 10.1016/0006-2952(79)90307-1. Biochem Pharmacol. 1979. PMID: 444264 No abstract available.
The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
Philips SR, Boulton AA. Philips SR, et al. J Neurochem. 1979 Jul;33(1):159-67. doi: 10.1111/j.1471-4159.1979.tb11718.x. J Neurochem. 1979. PMID: 572413 No abstract available.
The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
Fowler CJ, Oreland L, Callingham BA. Fowler CJ, et al. J Pharm Pharmacol. 1981 Jun;33(6):341-7. doi: 10.1111/j.2042-7158.1981.tb13800.x. J Pharm Pharmacol. 1981. PMID: 6115003 Review. No abstract available.
On the dual nature of monoamine oxidase.
Knoll J. Knoll J. Horiz Biochem Biophys. 1978;5:37-64. Horiz Biochem Biophys. 1978. PMID: 355087 Review. No abstract available.

See all similar articles

Cited by

From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiency.
Bortolato M, Floris G, Shih JC. Bortolato M, et al. J Neural Transm (Vienna). 2018 Nov;125(11):1589-1599. doi: 10.1007/s00702-018-1888-y. Epub 2018 May 10. J Neural Transm (Vienna). 2018. PMID: 29748850 Free PMC article. Review.
Monoamine oxidase inactivation: from pathophysiology to therapeutics.
Bortolato M, Chen K, Shih JC. Bortolato M, et al. Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1527-33. doi: 10.1016/j.addr.2008.06.002. Epub 2008 Jul 4. Adv Drug Deliv Rev. 2008. PMID: 18652859 Free PMC article. Review.
90 years of monoamine oxidase: some progress and some confusion.
Tipton KF. Tipton KF. J Neural Transm (Vienna). 2018 Nov;125(11):1519-1551. doi: 10.1007/s00702-018-1881-5. Epub 2018 Apr 10. J Neural Transm (Vienna). 2018. PMID: 29637260 Review.
A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys.
Yasar S, Gaál J, Panlilio LV, Justinova Z, Molnár SV, Redhi GH, Schindler CW. Yasar S, et al. Psychopharmacology (Berl). 2006 Jan;183(4):413-21. doi: 10.1007/s00213-005-0200-7. Epub 2005 Nov 15. Psychopharmacology (Berl). 2006. PMID: 16292593 Free PMC article.
Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.
Murphy DL, Sims KB, Karoum F, Garrick NA, de la Chapelle A, Sankila EM, Norio R, Breakefield XO. Murphy DL, et al. J Neural Transm Gen Sect. 1991;83(1-2):1-12. doi: 10.1007/BF01244447. J Neural Transm Gen Sect. 1991. PMID: 2018626

See all "Cited by" articles

References

1. Biochem Pharmacol. 1978;27(11):1606-8 - PubMed
1. Neurochem Res. 1979 Feb;4(1):53-62 - PubMed
1. Biochem Pharmacol. 1978;27(15):1889-93 - PubMed
1. J Neurochem. 1979 Jan;32(1):229-31 - PubMed
1. Eur J Pharmacol. 1975 Nov;34(1):181-7 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer